Impacts of the Finnish service screening programme on breast cancer rates View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2008-01-28

AUTHORS

Ahti Anttila, Tytti Sarkeala, Timo Hakulinen, Sirpa Heinävaara

ABSTRACT

BackgroundThe aim of the current study was to examine impacts of the Finnish breast cancer (BC) screening programme on the population-based incidence and mortality rates. The programme has been historically targeted to a rather narrow age band, mainly women of ages 50–59 years.MethodsThe study was based on the information on breast cancer during 1971–2003 from the files of the Finnish Cancer Registry. Incidence, cause-specific mortality as well as incidence-based (refined) mortality from BC were analysed with Poisson regression. Age-specific incidence and routine cause-specific mortality were estimated for the most recent five-year period available; incidence-based mortality, respectively, for the whole steady state of the programme, 1992–2003.ResultsThere was excess BC incidence with actual screening ages; incidence in ages 50–69 was increased 8% (95 CI 2.9–13.4). There was an increasing temporal tendency in the incidence of localised BC; and, respectively, a decrease in that of non-localised BC. The latter was most consistent in age groups where screening had been on-going several years or eventually after the last screen. The refined mortality rate from BC diagnosed in ages 50–69 was decreased with -11.1% (95% CI -19.4, -2.1).ConclusionsThe current study demonstrates that BC screening in Finland is effective in reducing mortality rates from breast cancers, even though the impact on the population level is smaller than expected based on the results from randomised trials among women screened in age 50 to 69. This may be explained by the rather young age group targeted in our country. Consideration whether to targeted screening up to age 69 is warranted. More... »

PAGES

38

References to SciGraph publications

  • 1994-05. Trends in cancer incidence and mortality in CANCER CAUSES & CONTROL
  • 2003. Is Mammography Screening for Breast Cancer Really Not Justifiable? in TUMOR PREVENTION AND GENETICS
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1186/1471-2458-8-38

    DOI

    http://dx.doi.org/10.1186/1471-2458-8-38

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1045649415

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/18226204


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Public Health and Health Services", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Breast Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Finland", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Incidence", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mammography", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mass Screening", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Program Evaluation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Registries", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Women's Health", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Mass Screening Registry, Finnish Cancer Registry, Helsinki, Finland", 
              "id": "http://www.grid.ac/institutes/grid.424339.b", 
              "name": [
                "Mass Screening Registry, Finnish Cancer Registry, Helsinki, Finland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Anttila", 
            "givenName": "Ahti", 
            "id": "sg:person.01220417437.14", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01220417437.14"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Mass Screening Registry, Finnish Cancer Registry, Helsinki, Finland", 
              "id": "http://www.grid.ac/institutes/grid.424339.b", 
              "name": [
                "Mass Screening Registry, Finnish Cancer Registry, Helsinki, Finland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sarkeala", 
            "givenName": "Tytti", 
            "id": "sg:person.0735360663.07", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735360663.07"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Finnish Cancer Registry, Helsinki, Finland", 
              "id": "http://www.grid.ac/institutes/grid.424339.b", 
              "name": [
                "Finnish Cancer Registry, Helsinki, Finland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hakulinen", 
            "givenName": "Timo", 
            "id": "sg:person.01302516444.80", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302516444.80"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Research and Environmental Surveillance, STUK Radiation and Nuclear Safety Authority, Helsinki, Finland", 
              "id": "http://www.grid.ac/institutes/grid.15935.3b", 
              "name": [
                "Finnish Cancer Registry, Helsinki, Finland", 
                "Research and Environmental Surveillance, STUK Radiation and Nuclear Safety Authority, Helsinki, Finland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hein\u00e4vaara", 
            "givenName": "Sirpa", 
            "id": "sg:person.01051607263.28", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051607263.28"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/bf01830253", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000218041", 
              "https://doi.org/10.1007/bf01830253"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-3-642-55647-0_11", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048953855", 
              "https://doi.org/10.1007/978-3-642-55647-0_11"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2008-01-28", 
        "datePublishedReg": "2008-01-28", 
        "description": "BackgroundThe aim of the current study was to examine impacts of the Finnish breast cancer (BC) screening programme on the population-based incidence and mortality rates. The programme has been historically targeted to a rather narrow age band, mainly women of ages 50\u201359 years.MethodsThe study was based on the information on breast cancer during 1971\u20132003 from the files of the Finnish Cancer Registry. Incidence, cause-specific mortality as well as incidence-based (refined) mortality from BC were analysed with Poisson regression. Age-specific incidence and routine cause-specific mortality were estimated for the most recent five-year period available; incidence-based mortality, respectively, for the whole steady state of the programme, 1992\u20132003.ResultsThere was excess BC incidence with actual screening ages; incidence in ages 50\u201369 was increased 8% (95 CI 2.9\u201313.4). There was an increasing temporal tendency in the incidence of localised BC; and, respectively, a decrease in that of non-localised BC. The latter was most consistent in age groups where screening had been on-going several years or eventually after the last screen. The refined mortality rate from BC diagnosed in ages 50\u201369 was decreased with -11.1% (95% CI -19.4, -2.1).ConclusionsThe current study demonstrates that BC screening in Finland is effective in reducing mortality rates from breast cancers, even though the impact on the population level is smaller than expected based on the results from randomised trials among women screened in age 50 to 69. This may be explained by the rather young age group targeted in our country. Consideration whether to targeted screening up to age 69 is warranted.", 
        "genre": "article", 
        "id": "sg:pub.10.1186/1471-2458-8-38", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1024954", 
            "issn": [
              "1471-2458"
            ], 
            "name": "BMC Public Health", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "8"
          }
        ], 
        "keywords": [
          "incidence-based mortality", 
          "cause-specific mortality", 
          "breast cancer", 
          "age 50", 
          "mortality rate", 
          "age groups", 
          "population-based incidence", 
          "breast cancer rates", 
          "age-specific incidence", 
          "Finnish Cancer Registry", 
          "narrow age bands", 
          "younger age groups", 
          "ConclusionsThe current study", 
          "Cancer Registry", 
          "BC incidence", 
          "screening age", 
          "age 69", 
          "cancer rates", 
          "MethodsThe study", 
          "current study", 
          "last screen", 
          "Poisson regression", 
          "incidence", 
          "mortality", 
          "age bands", 
          "cancer", 
          "five-year period", 
          "women", 
          "population level", 
          "group", 
          "registry", 
          "years", 
          "trials", 
          "study", 
          "rate", 
          "age", 
          "program", 
          "regression", 
          "aim", 
          "period", 
          "impact", 
          "levels", 
          "decrease", 
          "screen", 
          "Finland", 
          "Finnish service", 
          "services", 
          "countries", 
          "steady state", 
          "tendency", 
          "results", 
          "files", 
          "information", 
          "consideration", 
          "state", 
          "temporal tendency", 
          "band"
        ], 
        "name": "Impacts of the Finnish service screening programme on breast cancer rates", 
        "pagination": "38", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1045649415"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1186/1471-2458-8-38"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "18226204"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1186/1471-2458-8-38", 
          "https://app.dimensions.ai/details/publication/pub.1045649415"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-10-01T06:34", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_457.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1186/1471-2458-8-38"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1471-2458-8-38'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1471-2458-8-38'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1471-2458-8-38'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1471-2458-8-38'


     

    This table displays all metadata directly associated to this object as RDF triples.

    204 TRIPLES      21 PREDICATES      97 URIs      86 LITERALS      19 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1186/1471-2458-8-38 schema:about N16cdd6bae9d64ffeac933a576b0d6405
    2 N4664321499c647b682d34eeaa0cf855d
    3 N4f4f3fce53b84bbc8480f4b321ee8290
    4 N6181a7ceb7a349328c65c66f43eeb348
    5 N74203bda516b4e27880bad1899c3198c
    6 N80b619c32b964ea3bf4822c02da75e75
    7 Nbfe243b981c54b37957452ca11785295
    8 Nc3e26d2106814c65bcb5740cf18a8c62
    9 Ne5c9efb77b214211bd85a2021e6d1934
    10 Nf5a0b8bbb45446ab93c3891c64c695ea
    11 Nfd03ce91aa6e4f1eb4031dc68b6c0a00
    12 Nfeaeb62d646b40eb8db56672352e0351
    13 anzsrc-for:11
    14 anzsrc-for:1112
    15 anzsrc-for:1117
    16 schema:author N0e9f0fb3c3b04efc87bf4c33192fc1ff
    17 schema:citation sg:pub.10.1007/978-3-642-55647-0_11
    18 sg:pub.10.1007/bf01830253
    19 schema:datePublished 2008-01-28
    20 schema:datePublishedReg 2008-01-28
    21 schema:description BackgroundThe aim of the current study was to examine impacts of the Finnish breast cancer (BC) screening programme on the population-based incidence and mortality rates. The programme has been historically targeted to a rather narrow age band, mainly women of ages 50–59 years.MethodsThe study was based on the information on breast cancer during 1971–2003 from the files of the Finnish Cancer Registry. Incidence, cause-specific mortality as well as incidence-based (refined) mortality from BC were analysed with Poisson regression. Age-specific incidence and routine cause-specific mortality were estimated for the most recent five-year period available; incidence-based mortality, respectively, for the whole steady state of the programme, 1992–2003.ResultsThere was excess BC incidence with actual screening ages; incidence in ages 50–69 was increased 8% (95 CI 2.9–13.4). There was an increasing temporal tendency in the incidence of localised BC; and, respectively, a decrease in that of non-localised BC. The latter was most consistent in age groups where screening had been on-going several years or eventually after the last screen. The refined mortality rate from BC diagnosed in ages 50–69 was decreased with -11.1% (95% CI -19.4, -2.1).ConclusionsThe current study demonstrates that BC screening in Finland is effective in reducing mortality rates from breast cancers, even though the impact on the population level is smaller than expected based on the results from randomised trials among women screened in age 50 to 69. This may be explained by the rather young age group targeted in our country. Consideration whether to targeted screening up to age 69 is warranted.
    22 schema:genre article
    23 schema:isAccessibleForFree true
    24 schema:isPartOf Ne1f26c48573b4efdbc3611907aaa71ff
    25 Nf1d1ed9217804f13bd6e787e53370905
    26 sg:journal.1024954
    27 schema:keywords BC incidence
    28 Cancer Registry
    29 ConclusionsThe current study
    30 Finland
    31 Finnish Cancer Registry
    32 Finnish service
    33 MethodsThe study
    34 Poisson regression
    35 age
    36 age 50
    37 age 69
    38 age bands
    39 age groups
    40 age-specific incidence
    41 aim
    42 band
    43 breast cancer
    44 breast cancer rates
    45 cancer
    46 cancer rates
    47 cause-specific mortality
    48 consideration
    49 countries
    50 current study
    51 decrease
    52 files
    53 five-year period
    54 group
    55 impact
    56 incidence
    57 incidence-based mortality
    58 information
    59 last screen
    60 levels
    61 mortality
    62 mortality rate
    63 narrow age bands
    64 period
    65 population level
    66 population-based incidence
    67 program
    68 rate
    69 registry
    70 regression
    71 results
    72 screen
    73 screening age
    74 services
    75 state
    76 steady state
    77 study
    78 temporal tendency
    79 tendency
    80 trials
    81 women
    82 years
    83 younger age groups
    84 schema:name Impacts of the Finnish service screening programme on breast cancer rates
    85 schema:pagination 38
    86 schema:productId N78374b651878490486e00020402ad85d
    87 Na7f390ad079443e98c457012d46319db
    88 Nb48a7d640039445f8b4b5cf0b84cd127
    89 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045649415
    90 https://doi.org/10.1186/1471-2458-8-38
    91 schema:sdDatePublished 2022-10-01T06:34
    92 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    93 schema:sdPublisher N143a5cebdaa245d7ae7fcabef897e308
    94 schema:url https://doi.org/10.1186/1471-2458-8-38
    95 sgo:license sg:explorer/license/
    96 sgo:sdDataset articles
    97 rdf:type schema:ScholarlyArticle
    98 N0e9f0fb3c3b04efc87bf4c33192fc1ff rdf:first sg:person.01220417437.14
    99 rdf:rest Na2c4c3e050484e07bf8afbf351dde2b2
    100 N143a5cebdaa245d7ae7fcabef897e308 schema:name Springer Nature - SN SciGraph project
    101 rdf:type schema:Organization
    102 N16cdd6bae9d64ffeac933a576b0d6405 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    103 schema:name Program Evaluation
    104 rdf:type schema:DefinedTerm
    105 N3cfb1eedd01b4e1d82dae2a9de1809c9 rdf:first sg:person.01302516444.80
    106 rdf:rest N52b12c1b94814aee95c91666bc76ef58
    107 N4664321499c647b682d34eeaa0cf855d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    108 schema:name Humans
    109 rdf:type schema:DefinedTerm
    110 N4f4f3fce53b84bbc8480f4b321ee8290 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    111 schema:name Female
    112 rdf:type schema:DefinedTerm
    113 N52b12c1b94814aee95c91666bc76ef58 rdf:first sg:person.01051607263.28
    114 rdf:rest rdf:nil
    115 N6181a7ceb7a349328c65c66f43eeb348 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    116 schema:name Aged
    117 rdf:type schema:DefinedTerm
    118 N74203bda516b4e27880bad1899c3198c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    119 schema:name Incidence
    120 rdf:type schema:DefinedTerm
    121 N78374b651878490486e00020402ad85d schema:name pubmed_id
    122 schema:value 18226204
    123 rdf:type schema:PropertyValue
    124 N80b619c32b964ea3bf4822c02da75e75 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    125 schema:name Mass Screening
    126 rdf:type schema:DefinedTerm
    127 Na2c4c3e050484e07bf8afbf351dde2b2 rdf:first sg:person.0735360663.07
    128 rdf:rest N3cfb1eedd01b4e1d82dae2a9de1809c9
    129 Na7f390ad079443e98c457012d46319db schema:name doi
    130 schema:value 10.1186/1471-2458-8-38
    131 rdf:type schema:PropertyValue
    132 Nb48a7d640039445f8b4b5cf0b84cd127 schema:name dimensions_id
    133 schema:value pub.1045649415
    134 rdf:type schema:PropertyValue
    135 Nbfe243b981c54b37957452ca11785295 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    136 schema:name Mammography
    137 rdf:type schema:DefinedTerm
    138 Nc3e26d2106814c65bcb5740cf18a8c62 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    139 schema:name Middle Aged
    140 rdf:type schema:DefinedTerm
    141 Ne1f26c48573b4efdbc3611907aaa71ff schema:volumeNumber 8
    142 rdf:type schema:PublicationVolume
    143 Ne5c9efb77b214211bd85a2021e6d1934 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    144 schema:name Registries
    145 rdf:type schema:DefinedTerm
    146 Nf1d1ed9217804f13bd6e787e53370905 schema:issueNumber 1
    147 rdf:type schema:PublicationIssue
    148 Nf5a0b8bbb45446ab93c3891c64c695ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    149 schema:name Finland
    150 rdf:type schema:DefinedTerm
    151 Nfd03ce91aa6e4f1eb4031dc68b6c0a00 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    152 schema:name Breast Neoplasms
    153 rdf:type schema:DefinedTerm
    154 Nfeaeb62d646b40eb8db56672352e0351 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    155 schema:name Women's Health
    156 rdf:type schema:DefinedTerm
    157 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    158 schema:name Medical and Health Sciences
    159 rdf:type schema:DefinedTerm
    160 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    161 schema:name Oncology and Carcinogenesis
    162 rdf:type schema:DefinedTerm
    163 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
    164 schema:name Public Health and Health Services
    165 rdf:type schema:DefinedTerm
    166 sg:journal.1024954 schema:issn 1471-2458
    167 schema:name BMC Public Health
    168 schema:publisher Springer Nature
    169 rdf:type schema:Periodical
    170 sg:person.01051607263.28 schema:affiliation grid-institutes:grid.15935.3b
    171 schema:familyName Heinävaara
    172 schema:givenName Sirpa
    173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051607263.28
    174 rdf:type schema:Person
    175 sg:person.01220417437.14 schema:affiliation grid-institutes:grid.424339.b
    176 schema:familyName Anttila
    177 schema:givenName Ahti
    178 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01220417437.14
    179 rdf:type schema:Person
    180 sg:person.01302516444.80 schema:affiliation grid-institutes:grid.424339.b
    181 schema:familyName Hakulinen
    182 schema:givenName Timo
    183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302516444.80
    184 rdf:type schema:Person
    185 sg:person.0735360663.07 schema:affiliation grid-institutes:grid.424339.b
    186 schema:familyName Sarkeala
    187 schema:givenName Tytti
    188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735360663.07
    189 rdf:type schema:Person
    190 sg:pub.10.1007/978-3-642-55647-0_11 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048953855
    191 https://doi.org/10.1007/978-3-642-55647-0_11
    192 rdf:type schema:CreativeWork
    193 sg:pub.10.1007/bf01830253 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000218041
    194 https://doi.org/10.1007/bf01830253
    195 rdf:type schema:CreativeWork
    196 grid-institutes:grid.15935.3b schema:alternateName Research and Environmental Surveillance, STUK Radiation and Nuclear Safety Authority, Helsinki, Finland
    197 schema:name Finnish Cancer Registry, Helsinki, Finland
    198 Research and Environmental Surveillance, STUK Radiation and Nuclear Safety Authority, Helsinki, Finland
    199 rdf:type schema:Organization
    200 grid-institutes:grid.424339.b schema:alternateName Finnish Cancer Registry, Helsinki, Finland
    201 Mass Screening Registry, Finnish Cancer Registry, Helsinki, Finland
    202 schema:name Finnish Cancer Registry, Helsinki, Finland
    203 Mass Screening Registry, Finnish Cancer Registry, Helsinki, Finland
    204 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...